speb/financial-data huggingface dataset:
Financial ratios for SBI.TO — quarterly report dated 2025-09-30
Total revenue: 56751845.94594595
Gross profit: 29162102.702702705
Operating income: 25399275.675675675
Net income: 21602236.486486487
Capital expenditures: 11808127.027027028
Operating cash flow: 22265893.243243244
Depreciation & amortization: 3777636.4864864866
Net tangible assets: 208532628.3783784
Owner earnings: 13571745.945945946
Return on net tangible assets (%): 6.508212192731911
Capex to operating income (%): 46.49001482485349
Buffett classification: The Good
Stock price: 3.5755395683453237
P/E ratio: 5.81661508402921
Shares outstanding: 76307760
Book value: 208532628.3783784
P/B ratio: 1.308387168825845
Market cap (USD): 272841415.25179857
Debt to equity: 0.04175943819019313
Current ratio: 2.863515201514335
Quick ratio: 2.1197842416730697
Effective tax rate (%): 16.670723926329202
Interest coverage ratio: 149.65017994203637
COGS to revenue (%): 48.61470632959052
SG&A to revenue (%): 6.417841010338847
Free cash flow (dilution-adjusted): 10337182.432432432
Buyback yield (%): 0
Retained earnings: 198837093.24324325
Inventory turnover: 1.2196781705768347
Receivables turnover: 8.692596164991473
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.737144266368285
FCF margin (%): 18.214706958216333
Revenue growth (%): 18.59081549853194
Rule of 40 score: 36.80552245674827
Financial ratios for SBI.TO — annual report dated 2025-12-31
Total revenue: 210606756.75675675
Gross profit: 107218918.91891892
Operating income: 91794594.5945946
Net income: 72848648.64864865
Capital expenditures: 41008108.10810811
Operating cash flow: 75556756.75675675
Depreciation & amortization: 13041891.891891891
Net tangible assets: 229352702.7027027
Owner earnings: 44882432.432432435
Return on net tangible assets (%): 19.569175293570037
Capex to operating income (%): 44.673772229419384
Buffett classification: The Good
Stock price: 4.2627737226277365
P/E ratio: 4.465185287505233
Shares outstanding: 76307760
Book value: 229352702.70270273
P/B ratio: 1.4182641422029805
Market cap (USD): 325282714.16058385
Debt to equity: 0.042069042723057254
Current ratio: 3.4119228471451737
Quick ratio: 2.7213877272339335
Effective tax rate (%): 21.49358498259717
Interest coverage ratio: 117.52249134948097
COGS to revenue (%): 49.09046577135561
SG&A to revenue (%): 7.078646638733646
Free cash flow (dilution-adjusted): 34032432.432432435
Buyback yield (%): 0
Retained earnings: 223281081.0810811
Inventory turnover: 4.727907551600544
Receivables turnover: 14.688878416588125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.610591652409184
FCF margin (%): 16.15923105056818
Revenue growth (%): 78.22353960967821
Rule of 40 score: 94.3827706602464
Financial ratios for SBI.TO — quarterly report dated 2025-12-31
Total revenue: 69358095.94594595
Gross profit: 39791614.86486486
Operating income: 35898556.75675676
Net income: 25666748.64864865
Capital expenditures: 9732300
Operating cash flow: 23748272.972972974
Depreciation & amortization: 4291883.783783784
Net tangible assets: 229352702.7027027
Owner earnings: 20226332.432432435
Return on net tangible assets (%): 8.818876862615706
Capex to operating income (%): 27.11056064438636
Buffett classification: The Good
Stock price: 4.2627737226277365
P/E ratio: 4.482083421863476
Shares outstanding: 76307760
Book value: 229352702.70270273
P/B ratio: 1.4182641422029805
Market cap (USD): 325282714.16058385
Debt to equity: 0.042069042723057254
Current ratio: 3.4119228471451737
Quick ratio: 2.7213877272339335
Effective tax rate (%): 28.43141056227674
Interest coverage ratio: 118.62786969433095
COGS to revenue (%): 42.62873811317375
SG&A to revenue (%): 5.440084733770338
Free cash flow (dilution-adjusted): 13896054.054054054
Buyback yield (%): 0
Retained earnings: 223281081.0810811
Inventory turnover: 1.3520699542701766
Receivables turnover: 4.837416682375118
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.09963110537654
FCF margin (%): 20.035230011048615
Revenue growth (%): 22.212933852419518
Rule of 40 score: 42.248163863468136
Financial ratios for SKIN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.16
Shares outstanding: 129600040
Market cap (USD): 3131136966.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SKIN — annual report dated 2022-12-31
Total revenue: 365876000
Gross profit: 248779000
Operating income: -25841000
Net income: 44224000
Capital expenditures: 10847000
Operating cash flow: -106600000
Depreciation & amortization: 22873000
Net tangible assets: -3926000
Owner earnings: 56250000
Return on net tangible assets (%): -1432.7559857361182
Buffett classification: The Gruesome
Stock price: 9.1
P/E ratio: 26.667880879160634
Shares outstanding: 129600040
Book value: 167053000
P/B ratio: 7.059797573225264
Market cap (USD): 1179360364
Debt to equity: 4.500308285394456
Current ratio: 10.922204869342108
Quick ratio: 9.39313104833087
Effective tax rate (%): 2.459251417102274
Interest coverage ratio: -1.9295848267622462
COGS to revenue (%): 32.004558921601856
R&D to revenue (%): 2.3078857317779793
SG&A to revenue (%): 72.75033071313779
Free cash flow (dilution-adjusted): -152489000
Buyback yield (%): 13.566676046101206
Retained earnings: -378751000
Inventory turnover: 1.067857663967316
Receivables turnover: 4.704348496926993
Capitalized R&D asset: 8444000
ROCI (R&D-adjusted, %): -2.1506051381143556
FCF margin (%): -41.67778154347375
Rule of 40 score: -41.67778154347375
Financial ratios for SKIN — annual report dated 2023-12-31
Total revenue: 397991000
Gross profit: 155113000
Operating income: -130917000
Net income: -100116000
Capital expenditures: 3825000
Operating cash flow: 21750000
Depreciation & amortization: 34675000
Net tangible assets: -128551000
Owner earnings: -69266000
Buffett classification: The Gruesome
Stock price: 3.11
Shares outstanding: 129600040
Book value: 59390000
P/B ratio: 6.786599164842565
Market cap (USD): 403056124.4
Debt to equity: 12.666930459673345
Current ratio: 6.0713341680578745
Quick ratio: 5.277293753478019
Interest coverage ratio: -9.591691699025569
COGS to revenue (%): 61.02600310057262
R&D to revenue (%): 2.5382483523496764
SG&A to revenue (%): 69.3302109846705
Free cash flow (dilution-adjusted): -13843000
Buyback yield (%): 8.037342205933244
Retained earnings: -478867000
Inventory turnover: 2.6596073192365393
Receivables turnover: 7.232386559813916
Capitalized R&D asset: 15759480
ROCI (R&D-adjusted, %): -15.303342058934732
Rosenberg metric: -11.092610137375651
FCF margin (%): -3.478219356719122
Revenue growth (%): 8.777563983426079
Rule of 40 score: 5.299344626706957
Financial ratios for SKIN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.44
Shares outstanding: 129600040
Market cap (USD): 186624057.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SKIN — annual report dated 2024-12-31
Total revenue: 334294000
Gross profit: 182296000
Operating income: -67774000
Net income: -29098000
Capital expenditures: 756000
Operating cash flow: 16134000
Depreciation & amortization: 33680000
Net tangible assets: -119208000
Owner earnings: 3826000
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 129600040
Book value: 51803000
P/B ratio: 3.977840349014536
Market cap (USD): 206064063.60000002
Debt to equity: 10.967665965291586
Current ratio: 7.000880385021716
Quick ratio: 5.986779551590562
Interest coverage ratio: -6.509220130618517
COGS to revenue (%): 45.46836018594411
R&D to revenue (%): 1.8833721215457053
SG&A to revenue (%): 72.92203868451124
Free cash flow (dilution-adjusted): -17356000
Buyback yield (%): 0
Retained earnings: -507965000
Inventory turnover: 2.1992678656692664
Receivables turnover: 11.74568708056639
Capitalized R&D asset: 15850860
ROCI (R&D-adjusted, %): -11.013682435847889
Rosenberg metric: 2.690853296376955
FCF margin (%): -5.191837125404584
Revenue growth (%): -16.004633270601595
Rule of 40 score: -21.196470396006177
Financial ratios for SKIN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 129600040
Market cap (USD): 206064063.60000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SKIN — quarterly report dated 2025-03-31
Total revenue: 69580000
Gross profit: 48580000
Operating income: -12023000
Net income: -10096000
Capital expenditures: 45000
Operating cash flow: 2996000
Depreciation & amortization: 6164000
Net tangible assets: -123848000
Owner earnings: -3977000
Buffett classification: The Gruesome
Stock price: 1.34
Shares outstanding: 129600040
Book value: 46061000
P/B ratio: 3.770305759753371
Market cap (USD): 173664053.60000002
Debt to equity: 12.324678144200082
Current ratio: 7.473616330170053
Quick ratio: 6.428587351124132
Interest coverage ratio: -4.813050440352282
COGS to revenue (%): 30.181086519114686
R&D to revenue (%): 1.4343202069560217
SG&A to revenue (%): 85.66398390342053
Free cash flow (dilution-adjusted): -1625000
Buyback yield (%): 0
Retained earnings: -518061000
Inventory turnover: 0.3199658703071672
Receivables turnover: 2.9568247492775797
Capitalized R&D asset: 998000
ROCI (R&D-adjusted, %): -1.85578543410227
FCF margin (%): -2.3354412187410176
Rule of 40 score: -2.3354412187410176
Financial ratios for SKIN — quarterly report dated 2025-06-30
Total revenue: 78187000
Gross profit: 49112000
Operating income: -2700000
Net income: 19712000
Capital expenditures: 92000
Operating cash flow: 9646000
Depreciation & amortization: 5401000
Net tangible assets: -95760000
Owner earnings: 25021000
Return on net tangible assets (%): -26.128863826232244
Buffett classification: The Gruesome
Stock price: 1.91
P/E ratio: 25.742104450915143
Shares outstanding: 129600040
Book value: 74002000
P/B ratio: 3.3449917083322074
Market cap (USD): 247536076.39999998
Debt to equity: 5.090821869679198
Current ratio: 5.149761948823203
Quick ratio: 4.154035093622247
Effective tax rate (%): -5.304770553982585
Interest coverage ratio: -0.6515444015444015
COGS to revenue (%): 37.186488802486345
R&D to revenue (%): 1.60001023187998
SG&A to revenue (%): 64.66676045889982
Free cash flow (dilution-adjusted): 2786000
Buyback yield (%): 0
Retained earnings: -498349000
Inventory turnover: 0.49123963032422663
Receivables turnover: 2.882363783823638
Capitalized R&D asset: 1919660
ROCI (R&D-adjusted, %): -0.48854519285232606
Rosenberg metric: 0.533066132264529
FCF margin (%): 3.563252203051658
Revenue growth (%): 12.369933889048577
Rule of 40 score: 15.933186092100234
Financial ratios for SKIN — quarterly report dated 2025-09-30
Total revenue: 70655000
Gross profit: 45634000
Operating income: -6242000
Net income: -11031000
Capital expenditures: 27000
Operating cash flow: 9647000
Depreciation & amortization: 8433000
Net tangible assets: -98818000
Owner earnings: -2625000
Buffett classification: The Gruesome
Stock price: 1.99
Shares outstanding: 129600040
Book value: 65660000
P/B ratio: 3.927872062138288
Market cap (USD): 257904079.6
Debt to equity: 5.771855010660981
Current ratio: 4.981374386146291
Quick ratio: 4.074389377100026
Interest coverage ratio: -0.9890667089209317
COGS to revenue (%): 35.412921944660674
R&D to revenue (%): 2.403226947845163
SG&A to revenue (%): 71.01832849762933
Free cash flow (dilution-adjusted): 6108000
Buyback yield (%): 0
Retained earnings: -509380000
Inventory turnover: 0.44564171980194495
Receivables turnover: 2.7825693131695024
Capitalized R&D asset: 2865510
ROCI (R&D-adjusted, %): -1.317971094050137
Rosenberg metric: -2.78017585931255
FCF margin (%): 8.644823437831718
Revenue growth (%): -9.633315001215035
Rule of 40 score: -0.9884915633833167
Financial ratios for SKIN — annual report dated 2025-12-31
Total revenue: 300790000
Gross profit: 196364000
Operating income: -20803000
Net income: -9519000
Capital expenditures: 303000
Operating cash flow: 37485000
Depreciation & amortization: 25349000
Net tangible assets: -101328000
Owner earnings: 15527000
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 129600040
Book value: 61056000
P/B ratio: 2.9504726087526203
Market cap (USD): 180144055.6
Debt to equity: 6.203419811320755
Current ratio: 1.661613206281036
Quick ratio: 1.4038652529861764
Interest coverage ratio: -1.0764255407223429
COGS to revenue (%): 34.71724458924832
R&D to revenue (%): 1.8710728415173379
SG&A to revenue (%): 70.3278034509126
Free cash flow (dilution-adjusted): 17498000
Buyback yield (%): 0
Retained earnings: -517484000
Inventory turnover: 2.17499791718737
Receivables turnover: 12.833980458249776
Capitalized R&D asset: 13179980
ROCI (R&D-adjusted, %): -6.892087545581226
Rosenberg metric: 2.2344345616264296
FCF margin (%): 5.817347651185212
Revenue growth (%): -10.022315686192393
Rule of 40 score: -4.20496803500718
Financial ratios for SKIN — quarterly report dated 2025-12-31
Total revenue: 82368000
Gross profit: 53038000
Operating income: 162000
Net income: -8104000
Capital expenditures: 139000
Operating cash flow: 15196000
Depreciation & amortization: 5351000
Net tangible assets: -101328000
Owner earnings: -2892000
Capex to operating income (%): 85.80246913580247
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 129600040
Book value: 61056000
P/B ratio: 2.9504726087526203
Market cap (USD): 180144055.6
Debt to equity: 6.203419811320755
Current ratio: 1.661613206281036
Quick ratio: 1.4038652529861764
Interest coverage ratio: 0.025419739526125845
COGS to revenue (%): 35.608488733488734
R&D to revenue (%): 2.040841103341103
SG&A to revenue (%): 62.15399184149184
Free cash flow (dilution-adjusted): 10229000
Buyback yield (%): 0
Retained earnings: -517484000
Inventory turnover: 0.6108889444305591
Receivables turnover: 3.5144429747834622
Capitalized R&D asset: 3231490
ROCI (R&D-adjusted, %): 0.0946038480699242
Rosenberg metric: 4.360424028268551
FCF margin (%): 12.418657731157731
Revenue growth (%): 16.577736890524378
Rule of 40 score: 28.996394621682107
Financial ratios for SMP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.32
Shares outstanding: 22263279
Market cap (USD): 1008971804.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMP — annual report dated 2022-12-31
Total revenue: 1371815000
Gross profit: 382539000
Operating income: 106026000
Net income: 55435000
Capital expenditures: 25956000
Operating cash flow: -27533000
Depreciation & amortization: 28298000
Net tangible assets: 377416000
Owner earnings: 57777000
Return on net tangible assets (%): 15.308571973631219
Capex to operating income (%): 24.48078773131119
Buffett classification: The Great
Stock price: 30.91
P/E ratio: 12.413781074952647
Shares outstanding: 22263279
Book value: 621038000
P/B ratio: 1.1080770482482554
Market cap (USD): 688157953.89
Debt to equity: 0.45138783778126296
Current ratio: 2.359535296830078
Quick ratio: 0.66235984786356
Effective tax rate (%): 25.63356791278526
Interest coverage ratio: 9.986436846566827
COGS to revenue (%): 72.11438860196164
SG&A to revenue (%): 20.164963934641335
Free cash flow (dilution-adjusted): -61667000
Buyback yield (%): 4.309475728989455
Retained earnings: 564242000
Inventory turnover: 1.8038985430608487
Receivables turnover: 8.183198320189932
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.378646444830318
FCF margin (%): -4.495285443007986
Rule of 40 score: -4.495285443007986
Financial ratios for SMP — annual report dated 2023-12-31
Total revenue: 1358272000
Gross profit: 388826000
Operating income: 95319000
Net income: 34352000
Capital expenditures: 28633000
Operating cash flow: 144260000
Depreciation & amortization: 29022000
Net tangible assets: 408017000
Owner earnings: 34741000
Return on net tangible assets (%): 8.514596205550259
Capex to operating income (%): 30.03913175757194
Buffett classification: The Good
Stock price: 36.49
P/E ratio: 23.648901103574755
Shares outstanding: 22263279
Book value: 650873000
P/B ratio: 1.2481498705738294
Market cap (USD): 812387050.71
Debt to equity: 0.37670175287652125
Current ratio: 2.4459858740628997
Quick ratio: 0.7194696693321239
Effective tax rate (%): 22.477850115032552
Interest coverage ratio: 7.173854143147437
COGS to revenue (%): 71.37348042218348
SG&A to revenue (%): 21.614448357913584
Free cash flow (dilution-adjusted): 109029000
Buyback yield (%): 0
Retained earnings: 573226000
Inventory turnover: 1.8454565356024482
Receivables turnover: 8.474264109506993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.640022492273339
FCF margin (%): 8.027037294444707
Revenue growth (%): -0.9872322434147462
Rule of 40 score: 7.03980505102996
Financial ratios for SMP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.23
Shares outstanding: 22263279
Market cap (USD): 695282203.17
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.39
Shares outstanding: 22263279
Market cap (USD): 654317769.8100001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMP — annual report dated 2024-12-31
Total revenue: 1463849000
Gross profit: 423321000
Operating income: 88292000
Net income: 28476000
Capital expenditures: 44018000
Operating cash flow: 76693000
Depreciation & amortization: 31413000
Net tangible assets: 73373000
Owner earnings: 15871000
Return on net tangible assets (%): 21.630572553936734
Capex to operating income (%): 49.855026502967426
Buffett classification: The Good
Stock price: 29.39
P/E ratio: 22.9778680225453
Shares outstanding: 22263279
Book value: 630082000
P/B ratio: 1.0384644694023952
Market cap (USD): 654317769.8100001
Debt to equity: 1.048320694766713
Current ratio: 2.1122179658718085
Quick ratio: 0.6434502098645503
Effective tax rate (%): 26.199840516833582
Interest coverage ratio: 6.534339846062759
COGS to revenue (%): 71.08164844871295
SG&A to revenue (%): 22.891978612548154
Free cash flow (dilution-adjusted): 26548000
Buyback yield (%): 1.5937210452083654
Retained earnings: 575385000
Inventory turnover: 1.623096169564919
Receivables turnover: 6.946924577280644
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.408866086840383
FCF margin (%): 1.8135750340369805
Revenue growth (%): 7.772890849550016
Rule of 40 score: 9.586465883586996
Financial ratios for SMP — quarterly report dated 2025-03-31
Total revenue: 413379000
Gross profit: 124722000
Operating income: 25135000
Net income: 12741000
Capital expenditures: 9132000
Operating cash flow: -60220000
Depreciation & amortization: 10267000
Net tangible assets: 86381000
Owner earnings: 13876000
Return on net tangible assets (%): 16.06371771570137
Capex to operating income (%): 36.33180823552814
Buffett classification: The Good
Stock price: 23.89
P/E ratio: 10.43618505827643
Shares outstanding: 22263279
Book value: 652437000
P/B ratio: 0.8152047405496623
Market cap (USD): 531869735.31
Debt to equity: 1.1502106716817102
Current ratio: 2.3231239868580196
Quick ratio: 0.8170365611360451
Effective tax rate (%): 26.75075201857618
Interest coverage ratio: 3.2386290426491433
COGS to revenue (%): 69.82865602751954
SG&A to revenue (%): 24.1533798281964
Free cash flow (dilution-adjusted): -70902000
Buyback yield (%): 0
Retained earnings: 581174000
Inventory turnover: 0.438203628811892
Receivables turnover: 1.4721736498157019
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6883699622627317
FCF margin (%): -17.151814678539548
Rule of 40 score: -17.151814678539548
Financial ratios for SMP — quarterly report dated 2025-06-30
Total revenue: 493853000
Gross profit: 150889000
Operating income: 43418000
Net income: 25537000
Capital expenditures: 10163000
Operating cash flow: 54317000
Depreciation & amortization: 10925000
Net tangible assets: 114941000
Owner earnings: 26299000
Return on net tangible assets (%): 22.88043430977632
Capex to operating income (%): 23.40734257681146
Buffett classification: The Great
Stock price: 29.75
P/E ratio: 17.303217259261196
Shares outstanding: 22263279
Book value: 703459000
P/B ratio: 0.9415368205538631
Market cap (USD): 662332550.25
Debt to equity: 1.0468257567249832
Current ratio: 2.1629397967161843
Quick ratio: 0.8283724094513774
Effective tax rate (%): 26.96891476274165
Interest coverage ratio: 5.234237492465341
COGS to revenue (%): 69.44657620789992
SG&A to revenue (%): 21.771660797848753
Free cash flow (dilution-adjusted): 42403000
Buyback yield (%): 0
Retained earnings: 599601000
Inventory turnover: 0.5218873305019622
Receivables turnover: 1.509007852843218
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.866001334712492
FCF margin (%): 8.586158229270653
Revenue growth (%): 19.467365299156462
Rule of 40 score: 28.053523528427114
Financial ratios for SMP — quarterly report dated 2025-09-30
Total revenue: 499074000
Gross profit: 161794000
Operating income: 48418000
Net income: -4173000
Capital expenditures: 10039000
Operating cash flow: 91584000
Depreciation & amortization: 11201000
Net tangible assets: 108773000
Owner earnings: -3011000
Return on net tangible assets (%): -2.7681501843288316
Capex to operating income (%): 20.734024536329464
Buffett classification: The Great
Stock price: 39.85
P/E ratio: 26.013536670576165
Shares outstanding: 22263279
Book value: 692132000
P/B ratio: 1.2818243747579943
Market cap (USD): 887191668.15
Debt to equity: 0.9906462929036658
Current ratio: 1.9557887214137215
Quick ratio: 0.734322664010164
Effective tax rate (%): 28.532971221650467
Interest coverage ratio: 6.548282391127942
COGS to revenue (%): 67.53347199012572
SG&A to revenue (%): 22.719676841510477
Free cash flow (dilution-adjusted): 79331000
Buyback yield (%): 0
Retained earnings: 588450000
Inventory turnover: 0.4979721613583342
Receivables turnover: 1.6847574005245942
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.286080681296053
FCF margin (%): 15.895638722914837
Revenue growth (%): 1.0571971821574437
Rule of 40 score: 16.95283590507228
Financial ratios for SMP — quarterly report dated 2025-12-31
Total revenue: 385090000
Gross profit: 122003000
Operating income: 22116000
Net income: 8103000
Capital expenditures: 9390000
Operating cash flow: -28241000
Depreciation & amortization: 11455000
Net tangible assets: 116395000
Owner earnings: 10168000
Return on net tangible assets (%): 8.735770436874436
Capex to operating income (%): 42.45794899620184
Buffett classification: The Good
Stock price: 36.26
P/E ratio: 19.12591206738059
Shares outstanding: 22263279
Book value: 698262000
P/B ratio: 1.1561083039604045
Market cap (USD): 807266496.54
Debt to equity: 1.019812047626822
Current ratio: 2.129373988980649
Quick ratio: 0.6537985948097966
Effective tax rate (%): 28.447883477469276
Interest coverage ratio: 2.803397135251616
COGS to revenue (%): 68.31831519904438
SG&A to revenue (%): 25.943545664649818
Free cash flow (dilution-adjusted): -39618000
Buyback yield (%): 0
Retained earnings: 589448000
Inventory turnover: 0.36142196554026396
Receivables turnover: 1.6597276096888198
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4725083176479283
FCF margin (%): -10.287984626970319
Revenue growth (%): -22.83909800951362
Rule of 40 score: -33.12708263648394
Financial ratios for SMP — annual report dated 2025-12-31
Total revenue: 1791158000
Gross profit: 559408000
Operating income: 139087000
Net income: 42208000
Capital expenditures: 38724000
Operating cash flow: 57440000
Depreciation & amortization: 43848000
Net tangible assets: 116395000
Owner earnings: 47332000
Return on net tangible assets (%): 40.66497701791314
Capex to operating income (%): 27.84156678913198
Buffett classification: The Good
Stock price: 36.26
P/E ratio: 19.12591206738059
Shares outstanding: 22263279
Book value: 698262000
P/B ratio: 1.1561083039604045
Market cap (USD): 807266496.54
Debt to equity: 1.019812047626822
Current ratio: 2.129373988980649
Quick ratio: 0.6537985948097966
Effective tax rate (%): 27.701926295884117
Interest coverage ratio: 4.438144165416893
COGS to revenue (%): 68.76836102677709
SG&A to revenue (%): 23.48530950368421
Free cash flow (dilution-adjusted): 11214000
Buyback yield (%): 0
Retained earnings: 589448000
Inventory turnover: 1.6921455870271815
Receivables turnover: 7.719843116972675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.260569921174598
FCF margin (%): 0.6260754215987646
Revenue growth (%): 22.359478334172444
Rule of 40 score: 22.985553755771207
Financial ratios for SPENCERS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0596070156929975
Shares outstanding: 90012009
Market cap (USD): 95377356.23302123
Buyback yield (%): 0
Retained earnings: -81214070.94817355
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPENCERS.NS — annual report dated 2023-03-31
Total revenue: 288483118.14859927
Gross profit: 45415809.98781974
Operating income: -12437710.109622413
Net income: -25626894.0316687
Capital expenditures: 3075371.4981729602
Operating cash flow: 3257076.7356881853
Depreciation & amortization: 16044872.107186358
Net tangible assets: -59385066.99147382
Owner earnings: -12657393.422655303
Buffett classification: The Gruesome
Stock price: 0.630937880633374
Shares outstanding: 90012009
Book value: -18327490.864799023
Market cap (USD): 56791986.19001219
Debt to equity: -8.90940374974995
Current ratio: 0.4239475581293903
Quick ratio: 0.11584318177291361
Interest coverage ratio: -0.9531684195100004
COGS to revenue (%): 84.25703026253835
SG&A to revenue (%): 2.8484537374373344
Free cash flow (dilution-adjusted): 72545.67600487212
Buyback yield (%): 0
Retained earnings: -100881827.04019488
Inventory turnover: 7.544342109939066
Receivables turnover: 119.85882805422993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.247103279395441
FCF margin (%): 0.025147286423707966
Rule of 40 score: 0.025147286423707966
Financial ratios for SPENCERS.NS — annual report dated 2024-03-31
Total revenue: 271162033.81700444
Gross profit: 42474001.67885838
Operating income: -16939824.91905504
Net income: -31916416.836551145
Capital expenditures: 3832437.9421993042
Operating cash flow: 4207111.164408202
Depreciation & amortization: 15885489.866890514
Net tangible assets: -90210384.93824199
Owner earnings: -19863364.911859933
Buffett classification: The Gruesome
Stock price: 1.0952495201535508
Shares outstanding: 90012009
Book value: -49866686.6530759
Market cap (USD): 98585609.6653071
Debt to equity: -3.899688653017291
Current ratio: 0.3830926584840909
Quick ratio: 0.11043924339061795
Interest coverage ratio: -1.0140855181404618
COGS to revenue (%): 84.33630214341797
SG&A to revenue (%): 2.625100377221113
Free cash flow (dilution-adjusted): -65667.34620458088
Buyback yield (%): 0
Retained earnings: -131143950.11392254
Inventory turnover: 7.171170984845636
Receivables turnover: 89.40774422622978
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.60383002793862
FCF margin (%): -0.024217013451409995
Revenue growth (%): -6.004193397089059
Rule of 40 score: -6.028410410540469
Financial ratios for SPENCERS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -105314154.32393694
Buffett classification: The Gruesome
Stock price: 1.281055900621118
Shares outstanding: 90012009
Book value: -65224247.49163881
Market cap (USD): 115310415.25621118
Debt to equity: -2.810169223968029
Current ratio: 0.3588146755698981
Quick ratio: 0.1457279718365391
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPENCERS.NS — quarterly report dated 2025-03-31
Total revenue: 48149906.47650222
Gross profit: 9168389.05775076
Operating income: -4521054.477437456
Net income: -7996855.272387187
Capital expenditures: 0
Depreciation & amortization: 3182534.486789806
Net tangible assets: -116775415.01052138
Owner earnings: -4814320.785597381
Buffett classification: The Gruesome
Stock price: 0.7488621776169915
Shares outstanding: 90012009
Book value: -77344599.01800326
Market cap (USD): 67406589.07142024
Debt to equity: -2.3752083756231244
Current ratio: 0.25771392706780466
Quick ratio: 0.08368721638844748
Interest coverage ratio: -0.942035481222916
COGS to revenue (%): 80.95865656099446
Buyback yield (%): 0
Retained earnings: -156579003.97474864
Inventory turnover: 1.9618067444922567
Receivables turnover: 22.55658941050187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.619471916752723
Rule of 40 score: 0
Financial ratios for SPENCERS.NS — annual report dated 2025-03-31
Total revenue: 233247638.53168106
Gross profit: 45642202.478372686
Operating income: -21723591.302314706
Net income: -28800830.021042787
Capital expenditures: 1909632.920271218
Operating cash flow: 4373871.872808043
Depreciation & amortization: 16665887.304185174
Net tangible assets: -116775415.01052138
Owner earnings: -14044575.63712883
Buffett classification: The Gruesome
Stock price: 0.7488621776169915
Shares outstanding: 90012009
Book value: -77344599.01800326
Market cap (USD): 67406589.07142024
Debt to equity: -2.3752083756231244
Current ratio: 0.25771392706780466
Quick ratio: 0.08368721638844748
Interest coverage ratio: -1.1309116558570194
COGS to revenue (%): 80.43186942183198
SG&A to revenue (%): 2.8949123554161456
Free cash flow (dilution-adjusted): 1802162.730886135
Buyback yield (%): 0
Retained earnings: -156579003.97474864
Inventory turnover: 9.441541379703924
Receivables turnover: 109.26856557646389
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -55.83136861720139
FCF margin (%): 0.7726392182278641
Revenue growth (%): -13.982191662904464
Rule of 40 score: -13.2095524446766
Financial ratios for SPENCERS.NS — quarterly report dated 2025-06-30
Total revenue: 48658811.13971449
Gross profit: 10137222.09220688
Operating income: -3859162.1811373746
Net income: -7209255.792183478
Capital expenditures: 0
Depreciation & amortization: 3078352.44558858
Owner earnings: -4130903.3465948985
Buffett classification: The Gruesome
Stock price: 0.7483032997893753
Shares outstanding: 90012009
Market cap (USD): 67356283.35537094
Interest coverage ratio: -0.822540016660099
COGS to revenue (%): 79.16672879018812
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.0569172412839922
Rule of 40 score: 1.0569172412839922
Financial ratios for SPENCERS.NS — quarterly report dated 2025-09-30
Total revenue: 50185524.23900789
Gross profit: 10540901.916572716
Operating income: -3024780.1578354
Net income: -7191894.024802705
Capital expenditures: 0
Depreciation & amortization: 2628872.6042841035
Net tangible assets: -126656809.470124
Owner earnings: -4563021.420518601
Buffett classification: The Gruesome
Stock price: 0.628184892897407
Shares outstanding: 90012009
Book value: -88681860.20293123
Market cap (USD): 56544184.23314543
Debt to equity: -2.164125185082635
Current ratio: 0.23347345302059472
Quick ratio: 0.07493313444100788
Interest coverage ratio: -0.6582675388020081
COGS to revenue (%): 78.99613070420105
Buyback yield (%): 0
Inventory turnover: 1.8291819944736665
Receivables turnover: 16.605263452392055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -36.14229636634528
Revenue growth (%): 3.1375881644739283
Rule of 40 score: 3.1375881644739283
Financial ratios for SPENCERS.NS — quarterly report dated 2025-12-31
Total revenue: 56017511.4180684
Gross profit: 11872618.915005013
Operating income: -1820741.895956333
Net income: -6499420.741895957
Capital expenditures: 0
Depreciation & amortization: 2568285.618803609
Owner earnings: -3931135.1230923478
Buffett classification: The Gruesome
Stock price: 0.4583936727191712
Shares outstanding: 90012009
Market cap (USD): 41260935.39434109
Interest coverage ratio: -0.3768531626540748
COGS to revenue (%): 78.80552239031542
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.62085535120795
Rule of 40 score: 11.62085535120795
Financial ratios for SPXX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.19
Shares outstanding: 17976544
Market cap (USD): 237110615.35999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPXX — annual report dated 2022-12-31
Total revenue: -47001590
Net income: -47304098
Capital expenditures: 0
Net tangible assets: 265760349
Owner earnings: -47304098
Return on net tangible assets (%): -17.799531863197547
Buffett classification: The Gruesome
Stock price: 12.27
Shares outstanding: 17976544
Book value: 265760349
P/B ratio: 0.8299665307859752
Market cap (USD): 220572194.88
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 140180561
Receivables turnover: -235.8191679377057
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPXX — annual report dated 2023-12-31
Total revenue: 48143423
Net income: 47790027
Capital expenditures: 0
Net tangible assets: 292557743
Owner earnings: 47790027
Return on net tangible assets (%): 16.335245996206634
Buffett classification: The Gruesome
Stock price: 12.38
P/E ratio: 4.656821280306036
Shares outstanding: 17976544
Book value: 292557743
P/B ratio: 0.7607032117416903
Market cap (USD): 222549614.72000003
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.7313397719975167
Buyback yield (%): 0
Retained earnings: 174647318
Receivables turnover: 215.29314724217193
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPXX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 331172634
Buffett classification: The Gruesome
Stock price: 15.73
Shares outstanding: 17976544
Book value: 331172634
P/B ratio: 0.8538478367146725
Market cap (USD): 282771037.12
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 227708704
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPXX — annual report dated 2024-12-31
Total revenue: 60819035
Net income: 60517162
Capital expenditures: 0
Net tangible assets: 331172634
Owner earnings: 60517162
Return on net tangible assets (%): 18.273599865138614
Buffett classification: The Gruesome
Stock price: 15.73
P/E ratio: 4.672575973076861
Shares outstanding: 17976544
Book value: 331172634
P/B ratio: 0.8538478367146725
Market cap (USD): 282771037.12
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.4870794151863804
Buyback yield (%): 0
Retained earnings: 227708704
Receivables turnover: 388.8237606925034
Capitalized R&D asset: 0
Revenue growth (%): 26.32885492998701
Rule of 40 score: 26.32885492998701
Financial ratios for SPXX — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 323077966
Buffett classification: The Gruesome
Stock price: 16.36
Shares outstanding: 17976544
Book value: 323077966
P/B ratio: 0.9102950086048269
Market cap (USD): 294096259.84
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 219335346
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SSNE.SW — annual report dated 2022-12-31
Total revenue: 3118048458.091954
Gross profit: 749170115.3017242
Operating income: 482889344.08189654
Net income: 405948405.170977
Capital expenditures: 609963543.3821839
Operating cash flow: 72772657.2974138
Depreciation & amortization: 171584825.5
Net tangible assets: 2914960585.2428164
Owner earnings: -32430312.711206913
Return on net tangible assets (%): -1.1125472116291228
Capex to operating income (%): 126.31538692200589
Buffett classification: The Gruesome
Stock price: 18.967391304347824
P/E ratio: 21.02015599618839
Shares outstanding: 449882573
Book value: 3466970480.445402
P/B ratio: 2.4612551076585967
Market cap (USD): 8533098803.097825
Debt to equity: 0.4618935020902149
Current ratio: 1.4685115602350371
Quick ratio: 1.0785843107455932
Effective tax rate (%): 16.779503490985263
Interest coverage ratio: 5.29928826992861
COGS to revenue (%): 75.97310864885762
R&D to revenue (%): 4.848452439330361
SG&A to revenue (%): 1.9130862948452498
Free cash flow (dilution-adjusted): -545621172.170977
Buyback yield (%): 0
Retained earnings: 1728253783.340517
Inventory turnover: 3.2779132951885144
Receivables turnover: 4.622307878877986
Capitalized R&D asset: 151177096.52586207
ROCI (R&D-adjusted, %): 12.281099088416326
FCF margin (%): -17.49880348251105
Rule of 40 score: -17.49880348251105
Financial ratios for SSNE.SW — annual report dated 2023-12-31
Total revenue: 2682169502.8059072
Gross profit: 432698143.9409283
Operating income: 239746063.08438817
Net income: 107642453.17440225
Capital expenditures: 832581769.9507736
Operating cash flow: -27866610.18284107
Depreciation & amortization: 160580740.18002814
Net tangible assets: 2783387760.68917
Owner earnings: -564358576.5963433
Return on net tangible assets (%): -20.27595955428817
Capex to operating income (%): 347.27651384111084
Buffett classification: The Gruesome
Stock price: 21.023809523809526
P/E ratio: 87.86724237424326
Shares outstanding: 449882573
Book value: 3318263809.220816
P/B ratio: 2.850359726237164
Market cap (USD): 9458245522.833334
Debt to equity: 0.788843412724242
Current ratio: 1.3097611744263016
Quick ratio: 0.943105749223775
Effective tax rate (%): 22.628702124754913
Interest coverage ratio: 3.1500419448756722
COGS to revenue (%): 83.86760629824967
R&D to revenue (%): 4.936929559229294
SG&A to revenue (%): 1.6170424949505755
Free cash flow (dilution-adjusted): -866597547.766526
Buyback yield (%): 0
Retained earnings: 1702130915.2953587
Inventory turnover: 2.985965850577459
Receivables turnover: 4.088736023666704
Capitalized R&D asset: 233705473.68498582
ROCI (R&D-adjusted, %): 5.55606023976996
Rosenberg metric: -2.093385695541895
FCF margin (%): -32.30957427783551
Revenue growth (%): -13.979223259178497
Rule of 40 score: -46.288797537014005
Financial ratios for SSNE.SW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.190476190476193
Shares outstanding: 449882573
Market cap (USD): 9533225951.666668
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SSNE.SW — quarterly report dated 2024-12-31
Total revenue: 739190983.9643835
Gross profit: 92688115.37945205
Operating income: 27091350.693150684
Net income: -50945397.936986305
Capital expenditures: 71208936.22328767
Net tangible assets: 2584726533.660274
Owner earnings: -122154334.16027397
Return on net tangible assets (%): -4.726006119776594
Capex to operating income (%): 262.8474933931254
Buffett classification: The Gruesome
Stock price: 19.77777777777778
Shares outstanding: 449882573
Book value: 3086916079.823287
P/B ratio: 2.8823840120066513
Market cap (USD): 8897677554.88889
Debt to equity: 0.7531030578481743
Current ratio: 1.2350076551335452
Quick ratio: 0.8075284271708917
Interest coverage ratio: 1.2533734269697396
COGS to revenue (%): 87.4608704123591
R&D to revenue (%): 4.708801466500002
SG&A to revenue (%): -5.565353385221653
Free cash flow (dilution-adjusted): -50285477.978082195
Buyback yield (%): 0
Retained earnings: 1605898197.99726
Inventory turnover: 0.7897885713264368
Receivables turnover: 1.0358900953939387
Capitalized R&D asset: 34807035.89315069
ROCI (R&D-adjusted, %): 1.1303054575369083
FCF margin (%): -6.802772093944412
Rule of 40 score: -6.802772093944412
Financial ratios for SSNE.SW — annual report dated 2024-12-31
Total revenue: 2558866989.232877
Gross profit: 367241579.2972603
Operating income: 122744198.96986301
Net income: -43797957.8
Capital expenditures: 426828119.9041096
Operating cash flow: 254824270.4890411
Depreciation & amortization: 202821817.0109589
Net tangible assets: 2584726533.660274
Owner earnings: -267804260.6931507
Return on net tangible assets (%): -10.361028805391983
Capex to operating income (%): 347.73791632214517
Buffett classification: The Gruesome
Stock price: 19.77777777777778
Shares outstanding: 449882573
Book value: 3086916079.823287
P/B ratio: 2.8823840120066513
Market cap (USD): 8897677554.88889
Debt to equity: 0.7531030578481743
Current ratio: 1.2350076551335452
Quick ratio: 0.8075284271708917
Interest coverage ratio: 1.561621774456938
COGS to revenue (%): 85.64827398834998
R&D to revenue (%): 5.585757201481071
SG&A to revenue (%): 1.8512541277972052
Free cash flow (dilution-adjusted): -269258310.4369863
Buyback yield (%): 0
Retained earnings: 1605898197.99726
Inventory turnover: 2.677359661503768
Receivables turnover: 3.585954140512846
Capitalized R&D asset: 281539807.71941274
ROCI (R&D-adjusted, %): 2.6296342739868903
Rosenberg metric: -0.49432213469356007
FCF margin (%): -10.52255985051053
Revenue growth (%): -4.597118617747297
Rule of 40 score: -15.119678468257828
Financial ratios for SSNE.SW — quarterly report dated 2025-03-31
Total revenue: 661749945.3168044
Gross profit: 98013376.91184573
Operating income: 41042313.2493113
Net income: 6591097.17630854
Capital expenditures: 91393485.67630854
Net tangible assets: 2490581543.699724
Owner earnings: -84802388.5
Return on net tangible assets (%): -3.404923188101171
Capex to operating income (%): 222.6811269655766
Buffett classification: The Gruesome
Stock price: 20.227272727272727
P/E ratio: 345.1586760102488
Shares outstanding: 449882573
Book value: 3114308347.387052
P/B ratio: 2.9219642001579973
Market cap (USD): 9099897499.318182
Debt to equity: 0.745369060037629
Current ratio: 1.1039605407906992
Quick ratio: 0.6572540605025917
Effective tax rate (%): 37.4976743936901
Interest coverage ratio: 2.2944226963161114
COGS to revenue (%): 85.1887593485296
R&D to revenue (%): 4.609463662060813
SG&A to revenue (%): 4.667566727970849
Free cash flow (dilution-adjusted): -131963598.95041323
Buyback yield (%): 0
Retained earnings: 1622715172.946281
Inventory turnover: 0.6505623000827744
Receivables turnover: 1.0209849396254598
Capitalized R&D asset: 53823837.31149636
ROCI (R&D-adjusted, %): 1.1372374324597743
Rosenberg metric: 0.1529938242584334
FCF margin (%): -19.941610858348817
Revenue growth (%): -10.476458767428692
Rule of 40 score: -30.41806962577751
Financial ratios for SSNE.SW — quarterly report dated 2025-06-30
Total revenue: 704906514.9623431
Gross profit: 125199735.34588563
Operating income: 63436101.36262204
Net income: 26648728.785216175
Capital expenditures: 34044133.98465829
Net tangible assets: 2557478891.4895396
Owner earnings: -7395405.199442118
Return on net tangible assets (%): -0.2891677903599372
Capex to operating income (%): 53.6668131448536
Buffett classification: The Good
Stock price: 22.25
P/E ratio: 93.90586066907582
Shares outstanding: 449882573
Book value: 3184866824.642957
P/B ratio: 3.142953159547627
Market cap (USD): 10009887249.25
Debt to equity: 0.7152296481125623
Current ratio: 1.1074408872024932
Quick ratio: 0.629937752789299
Effective tax rate (%): 19.919814414360868
Interest coverage ratio: 3.4514532759985754
COGS to revenue (%): 82.23881710717713
R&D to revenue (%): 5.813978558103967
SG&A to revenue (%): -1.654724363813179
Free cash flow (dilution-adjusted): 190638469.78103206
Buyback yield (%): 0
Retained earnings: 1669426858.8270574
Inventory turnover: 0.6297694155207152
Receivables turnover: 1.3030289443219067
Capitalized R&D asset: 72906528.06559551
ROCI (R&D-adjusted, %): 1.5565571503822087
Rosenberg metric: 0.8912647468772678
FCF margin (%): 27.044503878818055
Revenue growth (%): 6.521582653834301
Rule of 40 score: 33.566086532652356
Financial ratios for SSNE.SW — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.25
Shares outstanding: 449882573
Market cap (USD): 10009887249.25
Buyback yield (%): 0
Capitalized R&D asset: 37524716.81199252
Rule of 40 score: 0
Financial ratios for SSNE.SW — annual report dated 2025-12-31
Total revenue: 3083859314.261429
Gross profit: 532711536.93142855
Operating income: 252020329.67714286
Net income: 74032284.55714285
Capital expenditures: 202462737.4557143
Operating cash flow: 322726632.8742857
Depreciation & amortization: 282383255.56
Net tangible assets: 2645768563.015714
Owner earnings: 153952802.66142857
Return on net tangible assets (%): 5.818831050209066
Capex to operating income (%): 80.33587517129448
Buffett classification: The Gruesome
Stock price: 22.531645569620252
P/E ratio: 136.9212735149452
Shares outstanding: 449882573
Book value: 3282026530.7842855
P/B ratio: 3.088516984158117
Market cap (USD): 10136594682.78481
Debt to equity: 0.7035681269988051
Current ratio: 1.0741364629037826
Quick ratio: 0.6106600645249566
Effective tax rate (%): 16.16427906762224
Interest coverage ratio: 2.9639222263368916
COGS to revenue (%): 82.7258158480874
R&D to revenue (%): 5.584931886921978
SG&A to revenue (%): 1.0414834027715445
Free cash flow (dilution-adjusted): 98581936.61
Buyback yield (%): 0
Retained earnings: 1752918170.5085714
Inventory turnover: 2.5280937564005863
Receivables turnover: 4.648043419829344
Capitalized R&D asset: 311693497.5395334
ROCI (R&D-adjusted, %): 6.002484465280471
Rosenberg metric: 1.1576822908201136
FCF margin (%): 3.196706677055725
Revenue growth (%): 20.516592977970287
Rule of 40 score: 23.713299655026013
Financial ratios for SSNE.SW — quarterly report dated 2025-12-31
Total revenue: 968273961.8057144
Gross profit: 180897824.87142855
Operating income: 102312681.43285714
Net income: 27160880.457142856
Capital expenditures: 28254637.235714287
Net tangible assets: 2645768563.015714
Owner earnings: -1093756.7785714306
Return on net tangible assets (%): -0.04133985087965286
Capex to operating income (%): 27.615967874184232
Buffett classification: The Good
Stock price: 22.531645569620252
P/E ratio: 167.8224524813169
Shares outstanding: 449882573
Book value: 3282026530.7842855
P/B ratio: 3.088516984158117
Market cap (USD): 10136594682.78481
Debt to equity: 0.7035681269988051
Current ratio: 1.0741364629037826
Quick ratio: 0.6106600645249566
Effective tax rate (%): -9.86306799577996
Interest coverage ratio: 3.9327368708118082
COGS to revenue (%): 81.31749566681769
R&D to revenue (%): 5.113501724739931
SG&A to revenue (%): -4.169329328226143
Free cash flow (dilution-adjusted): -42420764.64
Buyback yield (%): 0
Retained earnings: 1752918170.5085714
Inventory turnover: 0.7802608353035814
Receivables turnover: 1.4593984219546052
Capitalized R&D asset: 63037133.23655709
ROCI (R&D-adjusted, %): 2.8072702036699244
FCF margin (%): -4.38107047316344
Rule of 40 score: -4.38107047316344
Financial ratios for SVRN — annual report dated 2021-12-31
Capital expenditures: 0
Net tangible assets: 54714772.72727273
Buffett classification: The Gruesome
Stock price: 182757.15
Shares outstanding: 1875816
Book value: 54714772.72727273
P/B ratio: 6265.561730342728
Market cap (USD): 342818786084.39996
Debt to equity: 0
Current ratio: 3.4371643394199785
Quick ratio: 3.2373791621911923
Buyback yield (%): 0
Retained earnings: 73863.63636363637
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SVRN — annual report dated 2022-12-31
Total revenue: 20303191.489361703
Gross profit: 3860638.297872341
Operating income: -346808.5106382979
Net income: -346808.5106382979
Capital expenditures: 5419148.936170213
Operating cash flow: 1609574.4680851065
Net tangible assets: 81445744.68085107
Owner earnings: -5765957.44680851
Return on net tangible assets (%): -7.079507308089185
Buffett classification: The Gruesome
Stock price: 11100
Shares outstanding: 1875816
Book value: 81445744.68085106
P/B ratio: 255.64942258911432
Market cap (USD): 20821557600
Debt to equity: 0
Current ratio: 5.762911752745018
Quick ratio: 5.627084180561203
COGS to revenue (%): 80.98506680639245
SG&A to revenue (%): 16.1540476814252
Free cash flow (dilution-adjusted): -4413829.787234043
Buyback yield (%): 0
Retained earnings: -2469148.936170213
Inventory turnover: 46.27544910179641
Receivables turnover: 4.483204134366925
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4258153842134824
FCF margin (%): -21.739586062352632
Rule of 40 score: -21.739586062352632